Chemoinformaics analysis of DODECA-TRANS-2-TRANS-4-DIENOIC-ACID-ISOBUTYLAMIDE
| Molecular Weight | 194.274 | nRot | 7 |
| Heavy Atom Molecular Weight | 176.13 | nRig | 4 |
| Exact Molecular Weight | 194.131 | nRing | 0 |
| Solubility: LogS | -3.167 | nHRing | 0 |
| Solubility: LogP | 3.985 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 33.6463 |
| nHD | 1 | BPOL | 18.9257 |
| QED | 0.383 |
| Synth | 2.62 |
| Natural Product Likeliness | 1.886 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.026 |
| HIA | 0.01 |
| CACO-2 | -4.68 |
| MDCK | 0.0000249 |
| BBB | 0.84 |
| PPB | 0.945324 |
| VDSS | 0.352 |
| FU | 0.044971 |
| CYP1A2-inh | 0.074 |
| CYP1A2-sub | 0.424 |
| CYP2c19-inh | 0.032 |
| CYP2c19-sub | 0.119 |
| CYP2c9-inh | 0.151 |
| CYP2c9-sub | 0.686 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.287 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.099 |
| CL | 0.867 |
| T12 | 0.733 |
| hERG | 0.103 |
| Ames | 0.684 |
| ROA | 0.922 |
| SkinSen | 0.98 |
| Carcinogencity | 0.41 |
| EI | 0.979 |
| Respiratory | 0.955 |
| NR-Aromatase | 0.158 |
| Antiviral | No |
| Prediction | 0.657694 |